<DOC>
	<DOCNO>NCT00963261</DOCNO>
	<brief_summary>The purpose study analyse physical psychological side-effects course treatment IFN-alpha . The effectiveness specific intervention management side-effects evaluate .</brief_summary>
	<brief_title>Quality Life Psychological Well-being Patients With Malignant Melanoma</brief_title>
	<detailed_description>Today , consideration side effect intensive treatment measure influence quality life regard standard procedure oncology . Quality life measurement find way clinical study patient-reported outcome . In comparison tumor type , field dermato-oncology less research activity concern quality life . However , recent year attention pay health relate quality life malignant melanoma patient , especially adjuvant treatment interferon-alpha . Data high dose IFN-α treatment , especially USA , show significant physical psychological side effect , fatigue depression , often lead dosage reduction termination treatment . As yet , systematic study low dose IFN-α treatment , especially regard side effect course disease . Concerning treatment side-effects know throughout various area oncology specific psycho-oncological intervention assist patient ' adaptation illness handle side effect therapy .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<criteria>Documented proven stage Ib stage IIIc malignant melanoma No clinical radiological evidence suspicion persistent disease Treatment IFNα within study analog treatment schedule IFNα ECOG performance status &lt; 2 Constant care Informed consent participate study melanoma diagnosis within last 5 year therapy , recurrence progression within period time . Inoperable lymph node distant metastasis Tumors origins localisation within past 10 year Severe permanent infectious disease , e. g. HIV hepatitis Participation treatment study apart IFNα Insufficient knowledge German language</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>melanoma</keyword>
	<keyword>interferon-a</keyword>
	<keyword>quality life</keyword>
	<keyword>psychological distress</keyword>
	<keyword>depressive symptom</keyword>
	<keyword>side effect</keyword>
</DOC>